LONDONA tieup with AstraZeneca PLC would help deliver better drugs to patients Pfizer Inc Chief Executive Ian Read told UK lawmakers Wednesday hitting back at claims made by AstraZeneca that a deal could disrupt the development of new drugs  AstraZeneca rejected an unsolicited  billion takeover bid from Pfizer on May  On Tuesday Pfizer indicated that it was willing to alter the terms and structure of its proposal if AstraZeneca entered into talks but AstraZeneca rejected its advances again calling Pfizers
  